Lord, Abbett & Co. LLC Denali Therapeutics Inc. Transaction History

Lord, Abbett & Co. LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$36.89 - $93.56 $5.44 Million - $13.8 Million	-147,386 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$23.13 - $38.84 $208,355 - $349,870	-9,008 Reduced 5.76%	147,386 $5.28 Million
Q2 2020 Aug 14, 2020	SELL	$16.01 - $28.82 $1.33 Million - $2.4 Million	-83,108 Reduced 34.7%	156,394 $3.78 Million
Q1 2020 May 14, 2020	BUY	$14.2 - $27.98 $97,412 - $191,942	6,860 Added 2.95%	239,502 $4.19 Million
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $13.5 Million - $18.7 Million	-937,242 Reduced 80.11%	232,642 $4.05 Million
Q3 2019 Nov 14, 2019	SELL	$15.32 - $21.92 $8.82 Million - $12.6 Million	-576,042 Reduced 32.99%	1,169,884 $17.9 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $1.66 Million - $2.52 Million	89,677 Added 5.41%	1,745,926 $36.2 Million
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $3.92 Million - $5.36 Million	217,641 Added 15.13%	1,656,249 $38.5 Million
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $4.35 Million - $6.81 Million	313,153 Added 27.82%	1,438,608 $29.7 Million
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $9.49 Million - $16.6 Million	761,599 Added 209.31%	1,125,455 $24.5 Million
Q2 2018 Aug 14, 2018	BUY	$15.25 - $21.02 $1.21 Million - $1.67 Million	79,244 Added 27.84%	363,856 $5.55 Million
Q1 2018 May 15, 2018	BUY	$15.36 - $24.8 $4.37 Million - $7.06 Million	284,612 New	284,612 $5.6 Million

240

111M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.78B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.